Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
Rangering i aksjer #41523
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Aksjekurs
$0.05646911
Sist synkronisert: 2025-05-28
Markedsverdi
$17.31K
Endring (1 dag)
-1.67%
Endring (1 år)
0.00%
Land
US
Handel LungLife AI, Inc. (LLAI)

Kategori

P/S-forhold for LungLife AI, Inc. (LLAI)
P/S-forhold per 2026 TTM: 0
Ifølge LungLife AI, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for LungLife AI, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
4.61 -
US
5.46 -
US
- -
CN
9.92 -
US
15.33 -
US